Relebactam is a chemical compound used in combination with antibiotics to improve their efficacy.

As a beta-lactamase inhibitor,[1] it blocks the ability of bacteria to break down a beta-lactam antibiotic.

In the United States, relebactam is approved for use in the combination imipenem/cilastatin/relebactam (Recarbrio by Merck).

[2] This systemic antibiotic-related article is a stub.

You can help Wikipedia by expanding it.